Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy: findings from 7 open-label extension studies

被引：0
|
作者：
Murphy, K. [1 ]
Emir, B. [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1246
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [41] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [42] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    [J]. PLOS ONE, 2016, 11 (09):
  • [43] Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking
    Huffman, Cynthia
    Stacey, Brett R.
    Tuchman, Michael
    Burbridge, Claire
    Li, Chunming
    Parsons, Bruce
    Pauer, Lynne
    Scavone, Joseph M.
    Behar, Regina
    Yurkewicz, Lorraine
    [J]. CLINICAL JOURNAL OF PAIN, 2015, 31 (11): : 946 - 958
  • [44] Long-term safety and antihypertensive efficacy of irbesartan: Pooled results of five open-label studies
    Littlejohn, T
    Saini, R
    Kassler-Taub, K
    Crysant, SG
    Marbury, T
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (08) : 1273 - 1295
  • [45] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [46] Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy
    Beydoun, S.
    Alarcon, F.
    Mangat, S.
    Wan, Y.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (04): : 284 - 288
  • [47] LONG-TERM SAFETY OF PREGABALIN TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES: POOLED ANALYSIS OF SIX OPEN-LABEL CLINICAL STUDIES
    Schulze-Bonhage, A.
    Uthman, B.
    Bazil, C.
    Whalen, E.
    Leon, T.
    Emir, B.
    Benabou, R.
    [J]. EPILEPSIA, 2009, 50 : 201 - 201
  • [48] LONG TERM STUDY OF PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER: A 1 YEAR OPEN-LABEL EXTENSION
    Montgomery, S.
    Prieto, R.
    Emir, B.
    Haswell, H.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27
  • [49] Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: A retrospective analysis
    Caniggia, A
    Nuti, R
    Martini, G
    Frediani, B
    Giovani, S
    Valenti, R
    Silvestri, G
    Matarazzo, M
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (11): : 857 - 868
  • [50] Long-term Safety and Efficacy of OnabotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children With Cerebral Palsy: Open-label Extension Study
    Meilahn, J.
    Kim, H.
    Racette, B.
    Gul, F.
    Chambers, H.
    McCusker, E.
    Chen, K.
    Dimitrova, R.
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S99 - S100
12345